Roche signs deal with DKSH to expand access across Asia

15 October 2014
thailand

Switzerland-based market expansion services provider DKSH has signed an agreement with Swiss pharma major Roche (ROG: SIX) to extend its partnerships across Asian markets.

DKSH's Business Unit Healthcare will continue to provide market expansion services for Roche’s full pharmaceutical product portfolio in Cambodia, Hong Kong, Laos, Malaysia, Myanmar, Singapore, Thailand and Vietnam. The company is managing Roche’s entire supply chain operations for pharmaceutical products and distribution to hospitals, clinics and pharmacies in the region. The agreement is the first time that DKSH and Roche will work together in Singapore, while in the other Asian markets it extends an existing relationship that dates back to the 1940s.

Philippe Meyer, general manager, Roche Thailand Limited, said: “The extension of our agreement into new markets provides opportunities for Roche. DKSH is a reliable and professional partner that helps us grow our business across Asia, so that we can focus on our core business.”

Thomas Delemazure, regional business development director, DKSH Healthcare, added: “DKSH and Roche enjoy a long and successful collaboration. We are committed to utilize our in-depth health care expertise and network of unique scope and depth for growing Roche’s business in new and existing markets.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical